BRISTOL MYERS SQUIBB CO (BMY) Marketable Securities, Current USD 2010 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Bristol Myers Squibb Co quarterly Marketable Securities, Current history and growth rate from 2010 to 2023.
  • Bristol Myers Squibb Co Marketable Securities, Current for the quarter ending September 30, 2023 was $171M, a 86.8% decline year-over-year.
Marketable Securities, Current, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $171M -$1.12B -86.8% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $358M -$2.12B -85.6% Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $274M -$2.33B -89.5% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $130M -$2.86B -95.6% Dec 31, 2022 10-Q 2023-10-26
Q3 2022 $1.29B -$830M -39.1% Sep 30, 2022 10-Q 2022-10-26
Q2 2022 $2.48B +$532M +27.3% Jun 30, 2022 10-Q 2022-07-27
Q1 2022 $2.6B +$651M +33.4% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 $2.99B +$1.7B +132% Dec 31, 2021 10-K 2023-02-14
Q3 2021 $2.12B +$403M +23.4% Sep 30, 2021 10-Q 2021-10-27
Q2 2021 $1.95B +$222M +12.9% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 $1.95B -$557M -22.2% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $1.29B -$1.76B -57.8% Dec 31, 2020 10-K 2022-02-09
Q3 2020 $1.72B -$333M -16.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.72B +$771M +80.9% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $2.51B +$1.08B +75.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $3.05B +$1.2B +64.9% Dec 31, 2019 10-K 2021-02-10
Q3 2019 $2.05B +$631M +44.4% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $953M -$123M -11.4% Jun 30, 2019 10-Q 2019-07-25
Q1 2019 $1.43B +$1M +0.07% Mar 31, 2019 10-Q 2019-04-25
Q4 2018 $1.85B +$457M +32.9% Dec 31, 2018 10-K 2020-02-24
Q3 2018 $1.42B -$1.06B -42.6% Sep 30, 2018 10-Q 2018-10-25
Q2 2018 $1.08B -$1.96B -64.5% Jun 30, 2018 10-Q 2018-07-26
Q1 2018 $1.43B -$771M -35.1% Mar 31, 2018 10-Q 2018-04-26
Q4 2017 $1.39B -$722M -34.2% Dec 31, 2017 10-K 2019-02-25
Q3 2017 $2.48B +$350M +16.4% Sep 30, 2017 10-Q 2017-10-26
Q2 2017 $3.04B +$1.32B +76.8% Jun 30, 2017 10-Q 2017-07-27
Q1 2017 $2.2B +$536M +32.2% Mar 31, 2017 10-Q 2017-04-27
Q4 2016 $2.11B +$228M +12.1% Dec 31, 2016 10-K 2018-02-13
Q3 2016 $2.13B +$690M +48% Sep 30, 2016 10-Q 2016-10-27
Q2 2016 $1.72B +$440M +34.5% Jun 30, 2016 10-Q 2016-07-28
Q1 2016 $1.66B +$350M +26.7% Mar 31, 2016 10-Q 2016-04-28
Q4 2015 $1.89B +$21M +1.13% Dec 31, 2015 10-K 2017-02-21
Q3 2015 $1.44B -$932M -39.3% Sep 30, 2015 10-Q 2015-10-27
Q2 2015 $1.28B -$1.62B -55.9% Jun 30, 2015 10-Q 2015-07-23
Q1 2015 $1.31B -$521M -28.4% Mar 31, 2015 10-Q 2015-04-28
Q4 2014 $1.86B +$925M +98.5% Dec 31, 2014 10-K 2016-02-12
Q3 2014 $2.37B +$1.42B +149% Sep 30, 2014 10-Q 2014-10-24
Q2 2014 $2.89B +$1.92B +196% Jun 30, 2014 10-Q 2014-07-24
Q1 2014 $1.83B +$656M +55.7% Mar 31, 2014 10-Q 2014-04-29
Q4 2013 $939M -$234M -19.9% Dec 31, 2013 10-K 2015-02-13
Q3 2013 $951M -$476M -33.4% Sep 30, 2013 10-Q 2013-10-23
Q2 2013 $978M -$1.26B -56.3% Jun 30, 2013 10-Q 2013-07-25
Q1 2013 $1.18B -$1.54B -56.7% Mar 31, 2013 10-Q 2013-04-25
Q4 2012 $1.17B -$1.78B -60.3% Dec 31, 2012 10-K 2014-02-14
Q3 2012 $1.43B -$2.3B -61.7% Sep 30, 2012 10-Q 2012-10-24
Q2 2012 $2.24B -$1.77B -44.2% Jun 30, 2012 10-Q 2012-07-25
Q1 2012 $2.72B -$666M -19.7% Mar 31, 2012 10-Q 2012-04-26
Q4 2011 $2.96B +$689M +30.4% Dec 31, 2011 10-K 2013-02-15
Q3 2011 $3.72B +$2.94B +378% Sep 30, 2011 10-Q 2011-10-27
Q2 2011 $4.01B +$2.47B +161% Jun 30, 2011 10-Q 2011-07-28
Q1 2011 $3.39B +$1.75B +106% Mar 31, 2011 10-Q 2011-04-28
Q4 2010 $2.27B Dec 31, 2010 10-K 2012-02-17
Q3 2010 $778M Sep 30, 2010 10-Q 2010-10-26
Q2 2010 $1.54B Jun 30, 2010 10-Q 2010-07-22
Q1 2010 $1.64B Mar 31, 2010 10-Q 2010-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.